Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wellsted

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Clinical Kidney Journal|May 7, 2026
A new self-management engagement scale for haemodialysis patients (PRIESM CKD-HD): development and validationHelen Munro Wild, David Wellsted, Andrew Davenport, et al.
Frontiers in Nephrology|September 7, 2023
Frailty and the psychosocial components of the edmonton frail scale are most associated with patient experience in older kidney transplant candidates - a secondary analysis within the kidney transplantation in older people (KTOP) studyAmarpreet K Thind, Shuli Levy, David Wellsted, et al.
Journal of Renal Care|February 14, 2020
Antidepressant Usage in Haemodialysis Patients: Evidence of Sub-Optimal Practice PatternsAyman Guirguis, Joseph Chilcot, Michael Almond, et al.
Nephron. Clinical Practice|August 8, 2013
How robust is the 'surprise question' in predicting short-term mortality risk in haemodialysis patients?Maria Da Silva Gane, Andreas Braun, Dave Stott, et al.
British Journal of Health Psychology|September 12, 2014
Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patientsVari Wileman, Ken Farrington, David Wellsted, et al.
Journal of Psychosomatic Research|August 17, 2011
A confirmatory factor analysis of the Beck Depression Inventory-II in end-stage renal disease patientsJoseph Chilcot, Sam Norton, David Wellsted, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 26, 2009
Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis doseEnric Vilar, David Wellsted, Shahid M Chandna, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|September 4, 2012
Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptionsJoseph Chilcot, Sam Norton, David Wellsted, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 29, 2016
C reactive protein and depressive symptoms in hemodialysis patients: A questionable associationJoseph Chilcot, Karin Friedli, Ayman Guirguis, et al.
Nephron. Clinical Practice|August 12, 2011
Choosing not to take phosphate binders: the role of dialysis patients' medication beliefsVari Wileman, Joseph Chilcot, Sam Norton, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Clinical Kidney Journal|May 7, 2026
A new self-management engagement scale for haemodialysis patients (PRIESM CKD-HD): development and validationHelen Munro Wild, David Wellsted, Andrew Davenport, et al.
Frontiers in Nephrology|September 7, 2023
Frailty and the psychosocial components of the edmonton frail scale are most associated with patient experience in older kidney transplant candidates - a secondary analysis within the kidney transplantation in older people (KTOP) studyAmarpreet K Thind, Shuli Levy, David Wellsted, et al.
Journal of Renal Care|February 14, 2020
Antidepressant Usage in Haemodialysis Patients: Evidence of Sub-Optimal Practice PatternsAyman Guirguis, Joseph Chilcot, Michael Almond, et al.
Nephron. Clinical Practice|August 8, 2013
How robust is the 'surprise question' in predicting short-term mortality risk in haemodialysis patients?Maria Da Silva Gane, Andreas Braun, Dave Stott, et al.
British Journal of Health Psychology|September 12, 2014
Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patientsVari Wileman, Ken Farrington, David Wellsted, et al.
Journal of Psychosomatic Research|August 17, 2011
A confirmatory factor analysis of the Beck Depression Inventory-II in end-stage renal disease patientsJoseph Chilcot, Sam Norton, David Wellsted, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 26, 2009
Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis doseEnric Vilar, David Wellsted, Shahid M Chandna, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|September 4, 2012
Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptionsJoseph Chilcot, Sam Norton, David Wellsted, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 29, 2016
C reactive protein and depressive symptoms in hemodialysis patients: A questionable associationJoseph Chilcot, Karin Friedli, Ayman Guirguis, et al.
Nephron. Clinical Practice|August 12, 2011
Choosing not to take phosphate binders: the role of dialysis patients' medication beliefsVari Wileman, Joseph Chilcot, Sam Norton, et al.
Pageof 11